Sungsanpin
| Internal ID | 735acef9-9ae4-42f2-a8c1-ece273251af7 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(3S,6S,12S,19S,22S,25S)-3-(4-aminobutyl)-12-benzyl-22-[(2S)-butan-2-yl]-6-(hydroxymethyl)-2,5,8,11,14,17,21,24-octaoxo-1,4,7,10,13,16,20,23-octazabicyclo[23.3.0]octacosane-19-carbonyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylpentanoic acid |
| SMILES (Canonical) | CCC(C)C1C(=O)NC(CC(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)N1)CCCCN)CO)CC3=CC=CC=C3)C(=O)NC(CO)C(=O)NC(CC4=CC=CC=C4)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CC(C)C)C(=O)O |
| SMILES (Isomeric) | CC[C@H](C)[C@H]1C(=O)N[C@@H](CC(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N1)CCCCN)CO)CC3=CC=CC=C3)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC(C)C)C(=O)O |
| InChI | InChI=1S/C77H109N17O20/c1-7-44(6)65-75(111)89-55(34-61(98)80-36-62(99)84-52(31-45-19-10-8-11-20-45)66(102)81-38-64(101)85-57(39-95)71(107)86-50(25-16-17-27-78)76(112)94-28-18-26-60(94)74(110)93-65)70(106)92-58(40-96)72(108)87-53(32-46-21-12-9-13-22-46)67(103)82-37-63(100)83-51(29-42(2)3)68(104)91-59(41-97)73(109)88-54(69(105)90-56(77(113)114)30-43(4)5)33-47-35-79-49-24-15-14-23-48(47)49/h8-15,19-24,35,42-44,50-60,65,79,95-97H,7,16-18,25-34,36-41,78H2,1-6H3,(H,80,98)(H,81,102)(H,82,103)(H,83,100)(H,84,99)(H,85,101)(H,86,107)(H,87,108)(H,88,109)(H,89,111)(H,90,105)(H,91,104)(H,92,106)(H,93,110)(H,113,114)/t44-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,65-/m0/s1 |
| InChI Key | YXOZCEQVMZPWOG-YZZULCRUSA-N |
| Popularity | 5 references in papers |
| Molecular Formula | C77H109N17O20 |
| Molecular Weight | 1592.80 g/mol |
| Exact Mass | 1591.80347893 g/mol |
| Topological Polar Surface Area (TPSA) | 568.00 Ų |
| XlogP | -1.80 |
| Atomic LogP (AlogP) | -4.40 |
| H-Bond Acceptor | 20 |
| H-Bond Donor | 20 |
| Rotatable Bonds | 34 |
| CHEMBL2381503 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9132 | 91.32% |
| Caco-2 | - | 0.8647 | 86.47% |
| Blood Brain Barrier | - | 0.9000 | 90.00% |
| Human oral bioavailability | - | 0.6143 | 61.43% |
| Subcellular localzation | Mitochondria | 0.4088 | 40.88% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8284 | 82.84% |
| OATP1B3 inhibitior | + | 0.9346 | 93.46% |
| MATE1 inhibitior | - | 0.8266 | 82.66% |
| OCT2 inhibitior | - | 0.8250 | 82.50% |
| BSEP inhibitior | + | 0.9701 | 97.01% |
| P-glycoprotein inhibitior | + | 0.7419 | 74.19% |
| P-glycoprotein substrate | + | 0.8849 | 88.49% |
| CYP3A4 substrate | + | 0.7567 | 75.67% |
| CYP2C9 substrate | - | 0.8105 | 81.05% |
| CYP2D6 substrate | - | 0.8051 | 80.51% |
| CYP3A4 inhibition | - | 0.8496 | 84.96% |
| CYP2C9 inhibition | - | 0.8644 | 86.44% |
| CYP2C19 inhibition | - | 0.8887 | 88.87% |
| CYP2D6 inhibition | - | 0.9093 | 90.93% |
| CYP1A2 inhibition | - | 0.9079 | 90.79% |
| CYP2C8 inhibition | + | 0.7843 | 78.43% |
| CYP inhibitory promiscuity | - | 0.8627 | 86.27% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8500 | 85.00% |
| Carcinogenicity (trinary) | Non-required | 0.6154 | 61.54% |
| Eye corrosion | - | 0.9893 | 98.93% |
| Eye irritation | - | 0.8955 | 89.55% |
| Skin irritation | - | 0.7945 | 79.45% |
| Skin corrosion | - | 0.9380 | 93.80% |
| Ames mutagenesis | - | 0.7700 | 77.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7231 | 72.31% |
| Micronuclear | + | 0.8300 | 83.00% |
| Hepatotoxicity | - | 0.5625 | 56.25% |
| skin sensitisation | - | 0.8943 | 89.43% |
| Respiratory toxicity | + | 0.8222 | 82.22% |
| Reproductive toxicity | + | 0.9556 | 95.56% |
| Mitochondrial toxicity | + | 0.9375 | 93.75% |
| Nephrotoxicity | - | 0.6768 | 67.68% |
| Acute Oral Toxicity (c) | III | 0.5439 | 54.39% |
| Estrogen receptor binding | + | 0.5295 | 52.95% |
| Androgen receptor binding | + | 0.6072 | 60.72% |
| Thyroid receptor binding | + | 0.7482 | 74.82% |
| Glucocorticoid receptor binding | + | 0.8193 | 81.93% |
| Aromatase binding | + | 0.7836 | 78.36% |
| PPAR gamma | + | 0.7283 | 72.83% |
| Honey bee toxicity | - | 0.6653 | 66.53% |
| Biodegradation | - | 0.8750 | 87.50% |
| Crustacea aquatic toxicity | + | 0.5200 | 52.00% |
| Fish aquatic toxicity | + | 0.8822 | 88.22% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.99% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.84% | 96.61% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.53% | 91.11% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 99.27% | 97.64% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.22% | 96.09% |
| CHEMBL1801 | P00747 | Plasminogen | 98.43% | 92.44% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 98.36% | 90.17% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 97.47% | 94.45% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 97.47% | 82.38% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 97.21% | 90.08% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 97.12% | 97.14% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 97.00% | 96.31% |
| CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 96.74% | 91.71% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 96.57% | 94.45% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 96.54% | 88.56% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 96.54% | 90.20% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 96.21% | 97.09% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 95.68% | 95.56% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 93.83% | 98.33% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 93.52% | 88.42% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 93.48% | 83.82% |
| CHEMBL3155 | P34969 | Serotonin 7 (5-HT7) receptor | 93.25% | 90.71% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 92.99% | 97.23% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 92.79% | 91.81% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 91.75% | 96.90% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 91.66% | 96.67% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 91.56% | 98.89% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 91.12% | 95.83% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 90.92% | 98.05% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 90.42% | 94.66% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 90.37% | 96.11% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 89.79% | 95.89% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 89.70% | 99.17% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 89.31% | 98.24% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 88.44% | 98.94% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 88.43% | 83.10% |
| CHEMBL5896 | O75164 | Lysine-specific demethylase 4A | 88.09% | 99.09% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 87.98% | 90.24% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 87.20% | 95.50% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 87.18% | 89.00% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 86.97% | 89.33% |
| CHEMBL217 | P14416 | Dopamine D2 receptor | 86.35% | 95.62% |
| CHEMBL2535 | P11166 | Glucose transporter | 86.20% | 98.75% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 86.16% | 93.03% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 85.93% | 92.97% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 85.47% | 96.28% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 85.44% | 95.50% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 85.08% | 100.00% |
| CHEMBL3202 | P48147 | Prolyl endopeptidase | 84.82% | 90.65% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 84.56% | 96.47% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 84.38% | 95.93% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 84.21% | 82.86% |
| CHEMBL225 | P28335 | Serotonin 2c (5-HT2c) receptor | 84.02% | 89.62% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 83.53% | 93.56% |
| CHEMBL3729 | P22748 | Carbonic anhydrase IV | 83.15% | 99.23% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 83.10% | 98.59% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 82.82% | 96.67% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 82.81% | 93.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 82.17% | 90.71% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 82.02% | 100.00% |
| CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 81.88% | 88.10% |
| CHEMBL3384 | Q16512 | Protein kinase N1 | 81.48% | 80.71% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 81.14% | 99.18% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 80.45% | 100.00% |
| CHEMBL6175 | Q9H3R0 | Lysine-specific demethylase 4C | 80.42% | 96.69% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 71713252 |
| LOTUS | LTS0206852 |
| wikiData | Q77513842 |